Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (51-60 of 313) with videos related to

Pageof 32
Sort By:
Urology|July 3, 2003
Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancerBernd Straub, Markus Müller, Hans Krause, et al.
Urologia Internationalis|June 13, 2015
A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumKurt Miller, Rudolf Morant, Arnulf Stenzl, et al.
Aktuelle Urologie|March 28, 2018
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma]Kurt Miller, Jürgen E Gschwend, Axel Merseburger, et al.
World Journal of Urology|May 8, 2025
Characteristics of men using non-prescription medicines to treat their lower urinary tract symptomsMartin C Michel, Kurt Miller, Tim Schneider, et al.
BJU International|March 14, 2008
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?John Anderson, Per-Anders Abrahamsson, David Crawford, et al.
Cancer Detection and Prevention|October 28, 2006
Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesionsMartin Schostak, Kurt Miller, Hans Krause, et al.
Fertility and Sterility|April 16, 2005
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failureSteffen Weikert, Mark Schrader, Markus Müller, et al.
International Journal of Cancer|March 12, 2005
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosisSteffen Weikert, Frank Christoph, Mark Schrader, et al.
Urologia Internationalis|September 15, 2016
Is the Ellipsoid Formula the New Standard for 3-Tesla MRI Prostate Volume Calculation without Endorectal Coil?Matthias Haas, Karsten Günzel, Kurt Miller, et al.
BJU International|April 13, 2007
Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 yearsMartin Schostak, Hans Krause, Kurt Miller, et al.
Pageof 32

Showing results (51-60 of 313) with videos related to

Sort By:
Pageof 32
Urology|July 3, 2003
Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancerBernd Straub, Markus Müller, Hans Krause, et al.
Urologia Internationalis|June 13, 2015
A Phase II Study of the Central European Society of Anticancer-Drug Research (CESAR) Group: Results of an Open-Label Study of Gemcitabine plus Cisplatin with or without Concomitant or Sequential Gefitinib in Patients with Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumKurt Miller, Rudolf Morant, Arnulf Stenzl, et al.
Aktuelle Urologie|March 28, 2018
[Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma]Kurt Miller, Jürgen E Gschwend, Axel Merseburger, et al.
World Journal of Urology|May 8, 2025
Characteristics of men using non-prescription medicines to treat their lower urinary tract symptomsMartin C Michel, Kurt Miller, Tim Schneider, et al.
BJU International|March 14, 2008
Management of advanced prostate cancer: can we improve on androgen deprivation therapy?John Anderson, Per-Anders Abrahamsson, David Crawford, et al.
Cancer Detection and Prevention|October 28, 2006
Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesionsMartin Schostak, Kurt Miller, Hans Krause, et al.
Fertility and Sterility|April 16, 2005
Expression levels of the inhibitor of apoptosis survivin in testes of patients with normal spermatogenesis and spermatogenic failureSteffen Weikert, Mark Schrader, Markus Müller, et al.
International Journal of Cancer|March 12, 2005
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosisSteffen Weikert, Frank Christoph, Mark Schrader, et al.
Urologia Internationalis|September 15, 2016
Is the Ellipsoid Formula the New Standard for 3-Tesla MRI Prostate Volume Calculation without Endorectal Coil?Matthias Haas, Karsten Günzel, Kurt Miller, et al.
BJU International|April 13, 2007
Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 yearsMartin Schostak, Hans Krause, Kurt Miller, et al.
Pageof 32